Printer Friendly

Browse Anti-Alzheimer's disease agents topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Biogen slides as it admits Alzheimer's drug launch 'slower than anticipated'. Sep 9, 2021 394
INSIGHTS INTO THE NEW FDA-APPROVED ALZHEIMER'S DRUG. Wanagat, Jonathan Drug overview Sep 1, 2021 682
What You Should Know About the New Alzheimer's Disease Medication: Aducanumab was approved amid controversy, and there is still much debate about the amyloid-removing drug's place in Alzheimer's treatment. Aug 27, 2021 1556
New Research from Burke Neurological Institute Suggests Raising Vitamin B1 Levels May Provide Novel Treatment for Alzheimer's Disease. Aug 19, 2021 703
US FDA approves new Alzheimer's drug: A tortuous history and uncertain benefits have led to controversy over its approval. Aug 1, 2021 214
BioVie presents data on NE3107 in treatment of Alzheimer's disease. Jul 27, 2021 256
Cortexyme presents data linking P.gingivalis pathogen as agent in Alzheimer's. Jul 26, 2021 169
Biogen, Ionis report 'positive' data on Alzheimer's disease treatment. Clinical report Jul 26, 2021 222
India Globalization Capital issued Alzheimer's disease treatment patent. Jul 22, 2021 155
Medicare evaluating $56,000 Alzheimer's drug. RICARDO ALONSO- ZALDIVAR and MATTHEW PERRONE Associated Press -CLMN- Jul 19, 2021 672
Medicare evaluating coverage for $56,000 Alzheimer's drug. RICARDO ALONSO-ZALDIVAR and MATTHEW PERRONE Associated Press -CLMN- Jul 19, 2021 671
Amber Specialty Pharmacy to Dispense Aduhelm for the Treatment of Alzheimer's. Jul 12, 2021 225
FDA head calls for inquiry into Alzheimer's drug review. Associated Press Jul 10, 2021 252
FDA trims use of contentious Alzheimer's drug. MATTHEW PERRONE Associated Press Jul 9, 2021 393
FDA trims use of contentious Alzheimer's drug amid backlash. Jul 9, 2021 398
New Alzheimer's drug stirs hope Hope: Mayo Clinic to devise guidelines for new Alzheimer's drug. TOM MURPHY and MATTHEW PERRONE Associated Press Jul 5, 2021 1096
Alzheimer's drug stirs hope for patients, worry for doctors. TOM MURPHY and MATTHEW PERRONE Associated Press Jul 5, 2021 1096
New Alzheimer's drug welcomed. Jul 5, 2021 1463
The FDA approves first Alzheimers drug since 2003. Jul 1, 2021 167
ASHWAGANDHA'S Brain Benefits. Wilson, Rick Jul 1, 2021 2593
House committees to investigate approval, pricing of Biogen Alzheimer's drug. Jun 28, 2021 168
BioArctic AB awarded FDA's breakthrough therapy designation for lecanemab in Alzheimer's disease. Jun 24, 2021 228
BioArctic AB awarded FDA's breakthrough therapy designation for lecanemab in Alzheimer's disease. Jun 24, 2021 227
Australian research brings hope for new, non-invasive treatment for Alzheimer's disease. Jun 23, 2021 308
Artificial Intelligence Reveals Existing Drugs That May Treat Alzheimer's Disease: The AI method can evaluate whether drugs used for other conditions may work on Alzheimer's. Jun 22, 2021 432
Moody's confirms Biogen rating at Baa1 amid Alzheimer's treatment okay. Jun 11, 2021 179
Biogen's hefty price tag for new drug forecast to spark Alzheimer's research resurgence. Jun 10, 2021 539
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients. Jun 10, 2021 498
Breakthrough Alzheimer's drug is given green light. MARTIN BAGOT Health Editor Jun 8, 2021 211
Neurimmune announces FDA's approval for aducanumab for the treatment of Alzheimer's disease. Jun 8, 2021 262
Neurimmune announces FDA's approval for aducanumab for the treatment of Alzheimer's disease. Jun 8, 2021 263
THE FIRST NEW TREATMENT FOR ALZHEIMER'S IN ALMOST 20 YEARS FDA OKs drug, disregarding expert advice. MATTHEW PERRONE AP Health Writer Jun 8, 2021 1294
THE FIRST NEW TREATMENT FOR ALZHEIMER'S IN ALMOST 20 YEARS FDA OKs drug, disregarding expert advice Infusion: Drug reduces clumps of plaque in the brain. MATTHEW PERRONE AP Health Writer Jun 8, 2021 1294
FDA approves much-debated Alzheimer's drug panned by experts. MATTHEW PERRONE AP Health Writer Jun 8, 2021 1301
Alzheimer's drug: what is Biogen's aducanumab, will FDA approve it - and why is it controversial? Although some patient advocates are lobbying for the drug to be approved, some doctors remain unsure; Although some patient advocates are lobbying for the drug to be approved, some doctors remain unsure. Helen Johnson Jun 7, 2021 561
U.S. FDA approves Biogen Alzheimer's drug, hailed as 'a big day'. Reuters News Service Jun 7, 2021 476
US FDA approves Biogen Alzheimer's drug. Jun 7, 2021 319
Approval of Biogen Alzheimer's drug could be catalyst for RadNet, says Jefferies. Jun 7, 2021 187
FDA approves Biogen Alzheimer's drug, says benefits outweigh risks. Jun 7, 2021 212
AC Immune provides update on Alzheimer's disease vaccine candidates. Jun 2, 2021 302
dementia drug breakthrough; First treatment to slow down Alzheimer's could soon be approved in UK. MARTIN BAGOT May 29, 2021 330
DEMENTIA DRUG BREAKTHROUGH; First treatment to slow down Alzheimer's to be approved in US in days EXCLUSIVE. MARTIN BAGOT Health and Science Editor May 29, 2021 331
DEMENTIA DRUG BREAKTHROUGH; First treatment to slow down Alzheimer's could soon be approved in UK EXCLUSIVE. MARTIN BAGOT Health and Science Editor May 29, 2021 337
Annovis jumps after Alzheimer's drug shows 30% cognitive improvement in study. Clinical report May 21, 2021 195
India Globalization Capital Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients. May 14, 2021 409
ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's Disease. Apr 8, 2021 771
An anti-inflammation drug may help stop Alzheimer's. DR MIRIAM STOPPARD Apr 2, 2021 421
An anti-inflammation drug may help stop Alzheimer's; DM1ST mirror.co.uk FRIDAY 02.04.2021 DAILY MIRROR 39 Dr Miriam Stoppard. Dr Miriam Stoppard Apr 2, 2021 422
Novel Alzheimer's drug slows cognitive decline in trial. Brauser, Deborah Apr 1, 2021 1061
Novel Alzheimer's drug slows cognitive decline in trial. Brauser, Deborah Apr 1, 2021 853
WCM-Q Grand Rounds to focus on cancer therapies, Alzheimer's and data sharing in pandemics. Mar 25, 2021 405
PROBE OF ALZHEIMER'S DRUG APPROVAL. Corbett, Jessica Mar 22, 2021 994
Lilly Alzheimer's drug inspires more study. Robert Langreth Bloomberg Mar 14, 2021 653
IXICO announces second Alzheimer's clinical trial contract in the space of a week. Mar 11, 2021 250
IXICO brought in by new client to support Alzheimer's trial. Mar 3, 2021 168
A Pathophysiological and Pharmacological Review on Alzheimer's Disease: A Current Need. Sheela, D.; Rohan, R. Disease/Disorder overview Mar 1, 2021 3607
Exscientia, the University of Oxford Partner to Develop Treatments for Alzheimer's Disease. Feb 12, 2021 694
New hope in dementia drug: Drug 'reverses Alzheimer's in mice'; A drug that reverses Alzheimer's in mice has been developed by scientists. Mark Waghorn Feb 2, 2021 589
A test of the FDA's reputation in Biogen's experimental Alzheimer's drug. Nov 9, 2020 298
FDA advisers reject Alzheimer's drug. Laurie McGinley The Washington Post Nov 7, 2020 430
IXICO to supply its imaging expertise to leading Alzheimer's trial. Sep 22, 2020 309
Oligomerix Receives USD 3.19m NIH Commercialization Readiness Pilot Grant for Alzheimer's Disease Therapy. Sep 15, 2020 436
The Effects of a Recollection-Based Occupational Therapy Program of Alzheimer's Disease: A Randomized Controlled Trial. Kim, DeokJu Aug 31, 2020 5982
Annovis Bio recruiting patients for Phase 2a Alzheimer's and Parkinson's trials. Aug 20, 2020 161
Biogen to produce first therapy for Alzheimer's if FDA approves next year. Aug 11, 2020 285
Biogen to produce first therapy for Alzheimer's if FDA approves next year. Aug 11, 2020 283
Alzheimer's drug from Biogen to get speedy U.S. review. Reuters News Service Aug 7, 2020 397
Nootropic herbal formulations for the treatment of Alzheimer's disease: In vivo pharmacological assay and molecular docking studies. Kotla, Naveen Kumar; Kamila, Shibnath; Patel, Shivani; Kothapally, Joel; Kongara, Aparna; Madhav, Sa Aug 1, 2020 5678
Nootropic herbal formulations for the treatment of Alzheimer's disease: In vivo pharmacological assay and molecular docking studies. Kotla, Naveen Kumar; Kamila, Shibnath; Patel, Shivani; Kothapally, Joel; Kongara, Aparna; Madhav, Sa Aug 1, 2020 5747
Neurotrope signs agreement with Worldwide Clinical Trials for Alzheimer's study. Clinical report Jul 30, 2020 157
AC Immune advances phospho-Tau Alzheimer's vaccine in Phase 1b/2a study. Jul 16, 2020 251
Asthma drug could serve to treat Alzheimer's disease. Jul 11, 2020 160
Asthma drug could serve to treat Alzheimer's disease. Jul 8, 2020 370
Could psychedelic drugs cure depression, alzheimers and chronic pain? In the 1950s and 1960s, psychedelic drugs (including LSD) showed real potential to treat psychiatric disorders and addictions, including alcoholism. Then the counter-culture embraced LSD for recreational use, and medical trials of psychedelics largely dried up. Cultural and political attitudes hardened and for decades, psychedelics were off-limits. Jun 12, 2020 889
Network Pharmacology Study of Heat-Clearing and Detoxifying Traditional Chinese Medicine for Alzheimer's Disease. Li, Hongxing; Zhang, Xinyue; Gu, Lili; Wu, Ningzi; Zhang, Lingxi; Lu, Jiaqi; Li, Qin May 31, 2020 5735
Neurotrope launches Bryostatin clinical trial for Alzheimer's with NIH. May 28, 2020 184
Clinical Trials in Alzheimer's Disease: A Hurdle in the Path of Remedy. Oxford, Alexandra E.; Stewart, Erica S.; Rohn, Troy T. Apr 30, 2020 11212
Samsung Biologics forges Alzheimer's drug development partnership with Taiwan firm. Mar 17, 2020 470
Biogen and Sangamo Forge Global Collaboration to Develop Gene Regulation Therapies for Alzheimer's, Parkinson's, Neuromuscular, and Other Neurological Diseases. Mar 9, 2020 625
Downy Lavender Oil: A Promising Source of Antimicrobial, Antiobesity, and Anti-Alzheimer's Disease Agents. Ali-Shtayeh, Mohammed S.; Abu-Zaitoun, Salam Y.; Dudai, Nativ; Jamous, Rana M. Mar 1, 2020 6280
Eli Lilly's Solanezumab Dominantly Inherited Alzheimer Network Trials Unit Study fails to meet primary endpoint. Feb 10, 2020 189
Eli Lilly's Solanezumab Dominantly Inherited Alzheimer Network Trials Unit Study fails to meet primary endpoint. Feb 10, 2020 185
Alzheimer's Disease Global Clinical Trials Review, H2, 2019 - Pfizer Inc, Eisai Co Ltd, Allergan Plc & The Lundbeck Foundation. Jan 27, 2020 798
Neurotez developing a unique therapy to treat Alzheimer's disease. Jan 15, 2020 112
Biogen To Purchase Alzheimer's Drug From Pfizer. Dawn Geske Jan 14, 2020 291
Alzheimer's Vaccine: Human Trials Expected To Commence In 2 Years. Johnny Vatican Jan 8, 2020 526
ProMIS Neurosciences issues Chairman's Update detailing positive outlook for Alzheimer's disease therapy, pipeline in 2020. Jan 8, 2020 940
Tuberculosis Vaccine Found To Inadvertently Counter Alzheimer's Disease. Johnny Vatican Dec 30, 2019 475
Scientists find Tuberculosis vaccine lowers rate of Alzheimer's disease in cancer patients. ANI Dec 27, 2019 402
Study shows these Alzheimer's drug candidates reverse broader ageing. ANI Dec 15, 2019 374
Alzheimer's Drug Candidates Reverse Broader Aging, Study Shows. Dec 11, 2019 647
Grifols presents its latest Alzheimer's clinical trial data. Dec 9, 2019 608
Previously-Scrapped Alzheimer's Drug May Be Effective After All. Jan Cortes Dec 6, 2019 358
MedPharm to Conduct Clinical Trial Treating Dementia and Alzheimers with Cannabis. Dec 6, 2019 253
MedPharm to Conduct Clinical Trial Treating Dementia and Alzheimers with Cannabis. Dec 6, 2019 255
Aducanumab is good; next generation Alzheimer's disease therapies will be better. Dec 5, 2019 927
Eisai to Present Latest Data on Alzheimer's Disease / Dementia Pipeline at 12th Clinical Trials on Alzheimer's Disease Conference. Conference news Dec 2, 2019 924
Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019. Dec 2, 2019 1127
Biological Properties and Bioactive Components of Mentha spicata L. Essential Oil: Focus on Potential Benefits in the Treatment of Obesity, Alzheimer's Disease, Dermatophytosis, and Drug-Resistant Infections. Ali-Shtayeh, Mohammed S.; Jamous, Rana M.; Abu-Zaitoun, Salam Y.; Khasati, Ahmad I.; Kalbouneh, Same Nov 30, 2019 8511
A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Paeonia lactiflora Pall. On the Treatment of Alzheimer's Disease. Zeng, Qiang; Li, Longfei; Jin, Yu; Chen, Zongzheng; Duan, Lihong; Cao, Meiqun; Ma, Min; Wu, Zhengzhi Nov 30, 2019 5955
China OKs Seaweed-Based Alzheimer's Treatment. Darwin Malicdem Nov 7, 2019 400
Samsung BioLogics to produce Alzheimer's drugs. Nov 6, 2019 677
Biogen to Host Investor Webcasts from Clinical Trials on Alzheimer's Disease (CTAD) Congress on December 5, 2019. Nov 4, 2019 621
Chinese Regulators Tentatively Approve Novel Alzheimer's Drug -- The First Since 2003. Shanthi Rexaline Nov 4, 2019 507
Scientists identify critical window for treatment of Alzheimer's Disease. Disease/Disorder overview Oct 30, 2019 509
Fortunes for biotechs glimmer with Biogen, Dyadic and Genprex taking the lead after testing start to 2019. Oct 29, 2019 768
Scientists identify critical window for treatment of Alzheimer's Disease. Disease/Disorder overview Oct 29, 2019 504
Cambridge Cognition Senses Opportunity In Biogen's Alzheimer Drug Push. Oct 25, 2019 330
Alzheimer's 'wonder drug' offers new hope. Oct 23, 2019 206
Alzheimer's 'wonder drug' offers new hope. Oct 23, 2019 183
Health Highlights: Oct. 23, 2019; Smokeless Tobacco Snus can be Marketed as Less Risky Than Cigarettes: FDA New Alzheimer's Drug to be Submitted for FDA Approval. Oct 23, 2019 605
Biogen Plans Filing For Failed Alzheimer's Drug After New Analysis. Shanthi Rexaline Oct 22, 2019 639
Health Highlights: Oct. 22, 2019; New Alzheimer's Drug to be Submitted for FDA Approval More Choices, Lower Premiums for ACA Health Insurance Consumers Next Year $260 Million Deal Averts First Federal Trial Over Opioids. Oct 22, 2019 658
FCT[R] and the Brain: With an Approach Like This, Who Needs Neurotransmitters and Pills? Yurkovsky, Savely Oct 1, 2019 3658
Crusading medics questioning routine drugs' links with Alzheimer's disease. David Knight Sep 23, 2019 906
Cambridge Cognition Interim Revenue Falls As Clinical Trial Sales Lag. Financial report Sep 19, 2019 465
Scientists rethink Alzheimer's, diversifying the drug search. Sep 11, 2019 366
MRI Guided Ultrasound: treatment for Alzheimer's. Sep 1, 2019 203
Global Neurology Market Analysis & Forecast to 2024: Parkinson Diseases, Alzheimer Diseases, Psychotic Disorders, Epileptic Disorders, Autism Disorders, and Brain Tumor Diseases. Aug 15, 2019 1256
Clinical trials aim toward ending Alzheimer's. Jul 27, 2019 471
Eisai Presented Latest Trends of Treatment for Alzheimer's at AAIC 2019. Jul 19, 2019 1049
Alzamend Neuro Names McDade to Its Scientific Advisory Board. Jul 17, 2019 842
Androgen Deprivation Therapy May Up Risk of Alzheimer Disease; ADT exposure linked to subsequent Alzheimer disease diagnosis among elderly men at eight years. Jul 9, 2019 273
Hypertension drug may help Alzheimer's patients. Jun 17, 2019 562
Pfizer had clues drug could prevent Alzheimer's. Why didn't it tell the world? Jun 6, 2019 2061
Potential In Vitro and In Vivo Antioxidant Activities from Piper crocatum and Persea americana Leaf Extracts. Fatmawaty; Anggreni, Ni G.M.; Fadhil, Naufal; Prasasty, Vivitri D. Jun 1, 2019 3177
Plant-based vaccines for Alzheimer's disease. Ishiura, Shoichi; Yoshida, Taiji Report Jun 1, 2019 2813
Eisai Co., Ltd. - Alzheimer's Clinical Trials Consortium Selects Elenbecestat and BAN2401 for Upcoming Clinical Studies on Prevention of Alzheimer's Disease -- 10/5/2019. Clinical report May 21, 2019 841
Eisai Co., Ltd. - Alzheimer's Clinical Trials Consortium Selects Elenbecestat and BAN2401 for Upcoming Clinical Studies on Prevention of Alzheimer's Disease -- 10/5/2019. Clinical report May 15, 2019 893
Alzheimer's: How light therapy could protect the brain. May 9, 2019 385
New study offers potential new drug targets for Alzheimer's. Report May 5, 2019 656
New sound and light Alzheimer's therapy; DR MIRIAM STOPPARD; Helping to keep you fit and healthy. Apr 30, 2019 400
Blood drug 'could slow' Alzheimer's. Apr 19, 2019 109
First Patients Dosed in Amylyx Pharmaceuticals' PEGASUS Phase 2 Trial of AMX0035 in Alzheimer's Disease. Apr 8, 2019 537
Liver therapy hope for Alzheimer's. Apr 1, 2019 121
Modulation of Gut Microbiota through Mediterranean Diet as a New Insight for the Alzheimer's Disease Therapy. Fahira, Alessa; Widjaja, Hansel Tengara; Aditya, Nathaniel Report Apr 1, 2019 3125
Cortexyme to Present Preclinical and Clinical Data Supporting Its Novel Investigational Alzheimer's Treatment at AD/PD 2019. Mar 26, 2019 288
Intravenously Administered Autologous Bone Marrow and Adipose-Derived Stromal Cells in the Treatment of Alzheimer Disease: Case Studies. Camp, Kipp A. Van; Paspaliaris, Vasilis; Fair, Glen A.; Surmaczwicz, Cindii; Snyder, Larry; Weiss, M Clinical report Mar 22, 2019 4414
Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer's Disease. Mar 22, 2019 819
Eisai's Initiation of Phase III Clinical Trial of BAN2401 in Early Alzheimer's Disease. Clinical report Mar 22, 2019 388
Biogen downgraded to Neutral after Alzheimer's trial failures at BofA/Merrill. Mar 21, 2019 113
Light And Sound Treatment May Help Combat Alzheimer's, Study Finds. Mar 15, 2019 283
FDA issues warnings to companies selling illegal Alzheimer's treatments. Franki, Lucas Mar 1, 2019 207
HIV drug could treat Alzheimer's finds new study. Feb 7, 2019 549
LSU Health New Orleans: Hyperbaric oxygen therapy improves Alzheimer's. Jan 24, 2019 262
Including Sex and Gender in the Scientific Conversation. Karczmar, Alexa L.; Woodruff, Teresa K. Jan 1, 2019 1852
Eisai in collaboration with University College London to start Phase I clinical trials of Alzheimer's drug E2814. Dec 11, 2018 197
Eisai in collaboration with University College London to start Phase I clinical trials of Alzheimer's drug E2814. Dec 11, 2018 193
Final Patient Enrolled in Landmark Alzheimer's Treatment Trial Targeting Stress Hormone Cortisol. Clinical report Nov 26, 2018 179
Alzheimer's vaccine hopes. Nov 21, 2018 200
Alector Initiates Phase 1 Trial of AL002 for the Treatment of Patients with Alzheimer's Disease. Nov 19, 2018 396
Eisai and Biogen Announce Presentation of Additional Data From the Phase II Clinical Trial of BAN2401 in Early Alzheimer's Disease. Clinical report Oct 26, 2018 2126
vTv Therapeutics Presents Positive Data on the Effect of Azeliragon in Patients with Alzheimer's and Diabetes at the 11thClinical Trials on Alzheimer's Disease Conference. Conference news Oct 26, 2018 583
Green Valley Pharmaceutical updates Phase 3 clinical trial of GV-971 at 11th Clinical Trials on Alzheimer's Disease Conference in Barcelona, Spain. Conference news Oct 25, 2018 262
Green Valley Pharmaceutical updates Phase 3 clinical trial of GV-971 at 11th Clinical Trials on Alzheimer's Disease Conference in Barcelona, Spain. Conference news Oct 25, 2018 258
COLD SORES TREATMENT 'CUTS ALZHEIMER'S RISK' Virus could cause 50% of all cases. Oct 20, 2018 179
COLD SORES TREATMENT 'CUTS ALZHEIMER'S RISK' Virus could cause 50% of all cases. Oct 20, 2018 136
Eisai to Present Latest Data on Alzheimer's Disease / Dementia Pipeline at 11th Clinical Trials on Alzheimer's Disease Conference. Conference news Oct 18, 2018 1232
First clinical trial of Alzheimer's disease treatment starts at The National Institute for Health Research University College London Hospitals Clinical Research Facility. Oct 11, 2018 212
First clinical trial of Alzheimer's disease treatment starts at The National Institute for Health Research University College London Hospitals Clinical Research Facility. Oct 11, 2018 208
The Complexity of Pharmaceutical Prices: An Economic Analysis. Blackstone, Erwin A.; Fuhr, Joseph P., Jr. Report Oct 1, 2018 8930
Study identifies existing drug which could protect against Alzheimer's memory-loss. Sep 20, 2018 475
Study identifies existing drug which could protect against Alzheimer's memory-loss. Sep 20, 2018 471
NIH Grant For "Human-On-A-Chip" Model To Test Alzheimer's Drugs. Sep 10, 2018 311
Babs has heart op; Pacemaker is fitted due to Alzheimer's drug collapse. Sep 5, 2018 415
Babs heart op; Pacemaker is fitted due to Alzheimer's drug collapse. Sep 5, 2018 415
NIH Grant For Human-On-A-Chip Model To Test Alzheimer's Drugs. Sep 3, 2018 316
NIH Grant For Human-On-A-Chip Model To Test Alzheimer's Drugs. Sep 3, 2018 316
Promising New Alzheimer's Drug in Development. Sep 1, 2018 165
KinoPharma , National Institutes for Quantum and Radiological Science and Technology Launch Collaborative Research Project for Exploring New Drug Development for Alzheimer's Disease. Aug 30, 2018 800
Biogen and Eisai Report Data from Long-Term Extension Phase 1b Study of Investigational Alzheimer's Disease Treatment Aducanumab. Aug 29, 2018 1067
BioArctic announces exclusive rights to develop antibody treatments for Alzheimer's disease from a collaborative research project with Eisai. Aug 8, 2018 305
BioArctic acquires the exclusive rights to develop antibody based treatments for Alzheimer's Disease. Aug 8, 2018 249
BioArctic announces exclusive rights to develop antibody treatments for Alzheimer's disease from a collaborative research project with Eisai. Aug 8, 2018 301
BioArctic acquires the exclusive rights to develop antibody based treatments for Alzheimer's Disease. Aug 8, 2018 245
Design problem throws wrench in promising Alzheimer's trial. Sullivan, Michele G. Aug 1, 2018 821
Experimental Drug Slows Mental Decline in Alzheimer's Patients; However, the Phase 2 study of BAN2401 did not meet its primary end point. Jul 27, 2018 226
Medicine X Announces Launch of Alzheimer's Xplained Interactive Story. Jul 23, 2018 511
Oryzon Genomics enrols patients in UK trial of ORY2001 for Alzheimer's disease. Jun 25, 2018 215
Oryzon Genomics enrols patients in UK trial of ORY2001 for Alzheimer's disease. Jun 25, 2018 211
Eli Lilly, AstraZeneca Terminate Phase 3 Clinical Trials of Lanabecestat for Alzheimer's Disease. Jun 15, 2018 332
Treatments for Alzheimer's disease continue to evolve. Jun 13, 2018 541
AstraZeneca and Lilly end Alzheimer's trials. Jun 12, 2018 249
AstraZeneca and Lilly end Alzheimer's trials. Jun 12, 2018 245
Old asthma drug shows potential against Alzheimer's. Jun 12, 2018 629
Old asthma drug shows potential against Alzheimer's. Jun 12, 2018 625
Company Seeks Alzheimer s Patients For Stem Cell Trial In South Florida. Jun 4, 2018 324
Antiepileptic drugs increase risk of Alzheimer's and dementia. Report May 15, 2018 472
Neurotrope completes study design for Phase 2 trial in Alzheimer's. May 7, 2018 108
Music-Based Treatment for Anxiety in Alzheimer's. Apr 30, 2018 630
Antiepileptic drugs can increase Alzheimer's risk: Study. Apr 13, 2018 315
Antiepileptic drugs can increase Alzheimer's risk: Study. Apr 12, 2018 373
Antiepileptic drugs can increase Alzheimer's risk. Apr 10, 2018 362
IGC, Inc announces patent for Alzheimer's drug Hyalolex. Apr 10, 2018 268
Study finds antiepileptic drugs increase risk of Alzheimer's and dementia. Apr 9, 2018 251
Study finds antiepileptic drugs increase risk of Alzheimer's and dementia. Apr 9, 2018 247
Antiepileptic drugs increase risk of Alzheimer's. Apr 9, 2018 401
Alzheimer's Drugs Market Globally Expected to Drive Growth through 2025. Mar 26, 2018 870
Improving the Alzheimer's brain with cell therapy. Mar 16, 2018 356
Alzheimer's Drugs Market to Surge beyond US$ 15 Billion by 2025. Mar 16, 2018 786
University of West Florida conducting trial to treat agitation in Alzheimer's. Mar 14, 2018 494
University of West Florida conducting trial to treat agitation in Alzheimer's. Mar 14, 2018 490
An Alzheimer's Drug Has Been Shown to Help Teeth Repair Cavities Naturally. Mar 3, 2018 303
Morgan Stanley says Biogen Alzheimer trial change could be positive or negative. Feb 15, 2018 108
Analysts caution against overreacting to Biogen's Alzheimer's trial change. Feb 15, 2018 429
Eisai to Collaborate with Boston University School of Medicine to Study Effects of Alzheimer's Disease-associated Genetic Variants on Microglia. Feb 1, 2018 376
Molecular docking study on curcumin and its derivatives as inhibitors of BACE1 in the treatment of Alzheimer's disease. Raghu, Geetha; Karunanithi, Aishwarya; Kannan, Iyanar; Lakshmi, Preetha K. Report Feb 1, 2018 3079
Diabetes drug could treat Alzheimer's disease: Study. Jan 13, 2018 365
Lundbeck's Alzheimer's drug fails in Phase 3 trials. Jan 12, 2018 202
Lundbeck's Alzheimer's drug fails in Phase 3 trials. Jan 12, 2018 198
Diabetes drug could treat Alzheimer's disease: Study. Jan 3, 2018 438
Drug Reverses Memory Loss in Alzheimer's? Jan 2, 2018 622
Diabetes drug hope on Alzheimer's; NEWS WIRE. Jan 1, 2018 178
Diabetes drug could treat Alzheimer's disease. Jan 1, 2018 606
Diabetes drug could treat Alzheimer's after 'memory loss is reversed'. Jan 1, 2018 143
ALZHEIMER DRUG HOPE. Jan 1, 2018 107
New Hopes for Treatment of Alzheimer's Disease. Akhondzadeh, Shahin Report Jan 1, 2018 513
Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease. Kwak, Kyeong-Ah; Lee, Seung-Pyo; Yang, Jin-Young; Park, Young-Seok Jan 1, 2018 11739
Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences. de Andrade Teles, Roxana Braga; Diniz, Tamara Coimbra; Pinto, Tiago Coimbra Costa; de Oliveira, Raim Jan 1, 2018 13945
Alzheimer's drugs 'here in five years'. Dec 21, 2017 113
Alzheimer's drugs 'in 5 years'. Dec 21, 2017 163
This therapy holds promise for Alzheimer's disease treatment. Dec 6, 2017 366
Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease. Wu, Xi-Lin; Piña-Crespo, Juan; Zhang, Yun-Wu; Chen, Xiao-Chun; Xu, Hua-Xi Report Dec 1, 2017 10213
Alzheimer's wonder drug could be on the horizon. Nov 30, 2017 293
Alzheimer's wonder drug a step closer; Trials success for Scots prof's medication. Nov 30, 2017 266
Alzheimer's 'wonder drug' moves on to human trials. Nov 30, 2017 141
New Data From Long-Term Extension of Phase 1B Study of Investigational Alzheimer's Disease Treatment Aducanumab Presented at 10th Clinical Trials on Alzheimer's Disease. Nov 6, 2017 808
Biogen Presents New Data from Long-Term Extension of Phase 1b Study of Investigational Alzheimer's Disease Treatment Aducanumab. Nov 3, 2017 777
Eisai to Present Latest Data at 10th Clinical Trials on Alzheimer's Diesase. Oct 31, 2017 546
We'll give up everything to help baby Bonnie fight Alzheimer's; CLINICAL TRIAL OFFERS HOPE FOR TOT Heartbroken parents are raising funds for vital treatment in USA. Oct 30, 2017 780
Alzheimer's Association and Alzheimer's Drug Discovery Foundation Award USD 1.895m Grant to Amylyx to Conduct Combination Therapy Clinical Trial. Oct 25, 2017 388
Biogen and Eisai Expand Existing Collaboration Agreement to Develop and Commercialize Investigational Alzheimer's Disease Treatments Including Phase 3 Aducanumab. Oct 24, 2017 1193
PhRMA updates drug research for Alzheimer's. Oct 23, 2017 152
Ionis Earns USD 10m Milestone Payment with Initiation of Clinical Study of Antisense Drug in Alzheimer's Disease Patients. Report Oct 16, 2017 257
Biotechnology can Address the Mystery and Urgency of Alzheimer's Disease. Marmor, Mina; Miller, Henry I. Oct 1, 2017 1480
Alzheimer's: Future Treatment Options. Sep 22, 2017 170
Cognitive Stimulation Therapy for the Treatment of Alzheimer's. Sep 22, 2017 164
The Alzheimer's Drug Discovery Foundation honours Roberta Diaz Brinton, PhD. Sep 15, 2017 212
The Alzheimer's Drug Discovery Foundation honours Roberta Diaz Brinton, PhD. Sep 15, 2017 208
Fueling the Alzheimer's brain, upping cognition with fat. Sullivan, Michele G. Sep 15, 2017 2414
Phase 3 trials of Lilly's Alzheimer's therapy approved in Korea. Aug 8, 2017 227
Phase 3 trials of Lilly's Alzheimer's therapy approved in Korea. Aug 8, 2017 231
New Drug Research and Development for Alzheimer's Pathology: Present and Prospect. Wang, Tao Report Aug 1, 2017 1954
Activation of Two Different Drugs Used in Alzheimer's Disease Treatment on Human Carbonic Anhydrase Isozymes I and II Activity: an In Vitro Study/Alzheimer Hastaliginin Tedavisinde Kullanilan Iki Farkli Ilacin Insan Karbonik Anhidraz I ve II Izoenzim Aktiviteleri Uzerindeki Aktivasyonu: In Vitro Calisma. Dilek, Esra Report Aug 1, 2017 3185
Global Alzheimer's Drugs Market to Grow at a CAGR of 1.9% by 2021, Research and Markets Forecasts. Jul 20, 2017 347
UK-led Alzheimer's disease drug trial needs more participants. Jul 18, 2017 606
AXON Neuroscience completes recruitment round for Alzheimer's phase II clinical trial. Jul 18, 2017 265
UK-led Alzheimer's disease drug trial needs more participants. Jul 18, 2017 602
Link Between Parkinson's And Alzheimer's May Reveal New Treatment. Jul 8, 2017 708
Alzheimer's Disease: the Flagship Illness of a Greying World. Jun 30, 2017 3514
Araclon to begin phase II clinical trials of its Alzheimer's vaccine upon approval from the Spanish Agency of Medicinal Products and Medical Devices. Jun 28, 2017 328
Araclon to begin phase II clinical trials of its Alzheimer's vaccine upon approval from the Spanish Agency of Medicinal Products and Medical Devices. Jun 28, 2017 324
Anti-epilepsy drug to treat Alzheimer's disease? Jun 24, 2017 547
Enrollment of second Cohort begins in Alzheimer's trial. May 22, 2017 195
Cuba announces new trial for Alzheimer's drug. May 16, 2017 306
Cuba announces new trial for Alzheimer's drug. May 16, 2017 302
Enrollment of second Cohort begins in phase 1 trial stem cell treatment of Alzheimer's. May 15, 2017 189
Enrollment of second Cohort begins in phase 1 trial stem cell treatment of Alzheimer's. May 15, 2017 189
Longeveron to launch Phase 1 Alzheimer's disease trial of intravenous infusion of two different doses of Longeveron mesenchymal stem cells. May 11, 2017 247
Longeveron to launch Phase 1 Alzheimer's disease trial of intravenous infusion of two different doses of Longeveron mesenchymal stem cells. May 11, 2017 243
'REPURPOSED' DRUGS CAN REDUCE ALZHEIMER'S BRAIN SHRINKAGE. Apr 21, 2017 254
Genentech to begin second Phase 3 trial for Alzheimer's therapy. Apr 1, 2017 111
Stem cell trial for Alzheimer's reaches enrollment milestone. Clinical report Mar 27, 2017 280
Neuro-Bio Ltd secures USD3.2m funding to develop Alzheimer's disease treatment. Mar 24, 2017 255
Neuro-Bio Ltd secures USD3.2m funding to develop Alzheimer's disease treatment. Mar 24, 2017 251
Enrollment milestone reached in stem cell trial for Alzheimer's. Clinical report Mar 20, 2017 280
Enrollment milestone reached in stem cell trial for Alzheimer's. Clinical report Mar 20, 2017 280
Nature Cell starts Phase I and II clinical trials for 'ASTROSTEM', an Alzheimer's disease treatment. Mar 10, 2017 269
Nature Cell starts Phase I and II clinical trials for 'ASTROSTEM', an Alzheimer's disease treatment. Mar 10, 2017 265
Roche to make a comeback with failed Alzheimer's treatment. Mar 7, 2017 259
Roche to make a comeback with failed Alzheimer's treatment. Mar 7, 2017 255
Roche's Genentech to begin new Phase III trial of Alzheimer's drug. Mar 1, 2017 271
Roche's Genentech to begin new Phase III trial of Alzheimer's drug. Mar 1, 2017 267
Merck halts phase 2/3 clinical study of Alzheimer's drug. Clinical report Feb 16, 2017 177
Merck halts phase 2/3 clinical study of Alzheimer's drug. Clinical report Feb 16, 2017 173
Lundbeck's experimental Alzheimer's treatment has failed its phase III testing. Feb 9, 2017 205
Lundbeck's experimental Alzheimer's treatment has failed its phase III testing. Feb 9, 2017 201
Neurotrope signs licensing agreement for Alzheimer's drug with Stanford University. Feb 1, 2017 205
Neurotrope signs licensing agreement for Alzheimer's drug with Stanford University. Feb 1, 2017 201
Alzheimers Disease Drugs Market Globally Expected to Grow Till 2020. Jan 19, 2017 707
Lilly, AstraZeneca team up on Alzheimer's drug. Jan 2, 2017 303
Rapid Determination of Isomeric Benzoylpaeoniflorin and Benzoylalbiflorin in Rat Plasma by LC-MS/MS Method. Zhou, Chuanqi; Wang, Xiaoke Report Jan 1, 2017 4264
Andrographolide Activates Keap1/Nrf2/ARE/HO-1 Pathway in HT22 Cells and Suppresses Microglial Activation by A[[beta].sub.42] through Nrf2-Related Inflammatory Response. Seo, Ji Yeon; Pyo, Euisun; An, Jin-Pyo; Kim, Jinwoong; Sung, Sang Hyun; Oh, Won Keun Report Jan 1, 2017 6270
Xanthone and Flavone Derivatives as Dual Agents with Acetylcholinesterase Inhibition and Antioxidant Activity as Potential Anti-Alzheimer Agents. Cruz, Ines; Puthongking, Ploenthip; Cravo, Sara; Palmeira, Andreia; Cidade, Honorina; Pinto, Madalen Technical report Jan 1, 2017 11640
Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives. Femminella, Grazia Daniela; Bencivenga, Leonardo; Petraglia, Laura; Visaggi, Lucia; Gioia, Lucia; Gr Report Jan 1, 2017 6057
Anti-Parkinson Drug Biperiden Inhibits Enzyme Acetylcholinesterase. Kostelnik, Adam; Cegan, Alexander; Pohanka, Miroslav Report Jan 1, 2017 2694
A[beta] Peptide Originated from Platelets Promises New Strategy in Anti-Alzheimer's Drug Development. Inyushin, Mikhail Y.; Sanabria, Priscila; Rojas, Legier; Kucheryavykh, Yuriy; Kucheryavykh, Lilia Report Jan 1, 2017 8443
These Are The Top Pharma And Biotech Trends Taking Over 2017. Dec 28, 2016 692
AstraZeneca expands collaboration with Eli Lilly to produce experimental Alzheimer's drug. Dec 13, 2016 155
AstraZeneca expands collaboration with Eli Lilly to produce experimental Alzheimer's drug. Dec 13, 2016 151
Lilly partners with AstraZeneca to co-develop second potentially disease-modifying treatment for Alzheimer's Disease. Dec 12, 2016 207
Lilly partners with AstraZeneca to co-develop second potentially disease-modifying treatment for Alzheimer's Disease. Dec 12, 2016 203
Alzheimer's drug Solanezumab falls short in trial. Dec 12, 2016 315
FDA approves Korean company's Phase 1 and 2 Alzheimer's clinical trials. Nov 28, 2016 296
FDA approves Korean company's Phase 1 and 2 Alzheimer's clinical trials. Nov 28, 2016 295
Allergan Acquires Alzheimer's Treatment Specialist Chase Pharmaceuticals. Nov 25, 2016 138
Alzheimer's 'wonder drug' axed after flopping in trial. Nov 24, 2016 139
Allergan Acquires Alzheimer's Treatment Specialist Chase Pharmaceuticals. Nov 23, 2016 138
Allergan Acquires Alzheimer's Treatment Specialist Chase Pharmaceuticals. Nov 23, 2016 139
Alzheimer's drug shows promise: in small clinical trial, antibody reduced brain plaques. Sanders, Laura Oct 1, 2016 696

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |